SCICLONE PHARMACEUTICALS INC (SCLN) Stock Price, Quote, News and Overview
NASDAQ:SCLN - Nasdaq - US80862K1043
SCLN Quote, Performance and Key Statistics
11.15
0 (0%)
The current stock price of SCLN is 11.15 null. In the past month the price increased by 0.45%. In the past year, price increased by 11.39%.
About SCLN
Company Profile
Sciclone Pharmaceuticals, Inc. develops and commercializes novel medicines for treating a broad range of the world's most serious diseases. They have focused their current product development and commercial activities on the following diseases: hepatitis C, hepatocellular carcinoma, malignant melanoma, hepatitis B, HIV, drug-resistant tuberculosis, cystic fibrosis and others.
Company Info
SCICLONE PHARMACEUTICALS INC
950 TOWER LANE SUITE 900
FOSTER CITY CA 94404
CEO: Friedhelm Blobel
Phone: 650-358-3456
SCICLONE PHARMACEUTICALS INC / SCLN FAQ
What is the stock price of SCICLONE PHARMACEUTICALS INC today?
The current stock price of SCLN is 11.15 null.
What is the ticker symbol for SCICLONE PHARMACEUTICALS INC stock?
The exchange symbol of SCICLONE PHARMACEUTICALS INC is SCLN and it is listed on the Nasdaq exchange.
On which exchange is SCLN stock listed?
SCLN stock is listed on the Nasdaq exchange.
What is SCICLONE PHARMACEUTICALS INC worth?
SCICLONE PHARMACEUTICALS INC (SCLN) has a market capitalization of 581.92M null. This makes SCLN a Small Cap stock.
What are the support and resistance levels for SCICLONE PHARMACEUTICALS INC (SCLN) stock?
SCICLONE PHARMACEUTICALS INC (SCLN) has a support level at 11.15 and a resistance level at 11.19. Check the full technical report for a detailed analysis of SCLN support and resistance levels.
Should I buy SCICLONE PHARMACEUTICALS INC (SCLN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of SCLN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of SCLN, evaluating the profitability, health, valuation and growth aspects
- SCICLONE PHARMACEUTICALS INC (SCLN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- SCICLONE PHARMACEUTICALS INC (SCLN) Sales and EPS estimates to see what analysts future expectations are.
- SCICLONE PHARMACEUTICALS INC (SCLN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- SCICLONE PHARMACEUTICALS INC (SCLN) Insider and Institutional Ownership to learn about the owners and their transactions.
- SCICLONE PHARMACEUTICALS INC (SCLN) Stock Chart to make your own analysis
- SCICLONE PHARMACEUTICALS INC (SCLN) Latest news and press-releases to stay up to date.
Does SCICLONE PHARMACEUTICALS INC (SCLN) stock pay dividends?
SCLN does not pay a dividend.
What is the Price/Earnings (PE) ratio of SCICLONE PHARMACEUTICALS INC (SCLN)?
The PE ratio for SCICLONE PHARMACEUTICALS INC (SCLN) is 13.64. This is based on the reported non-GAAP earnings per share of 0.82 and the current share price of 11.15 null. Check the full fundamental report for a full analysis of the valuation metrics for SCLN.
SCLN Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to SCLN. When comparing the yearly performance of all stocks, SCLN turns out to be only a medium performer in the overall market: it outperformed 64.39% of all stocks.
SCLN Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to SCLN. While SCLN has a great health rating, its profitability is only average at the moment.
SCLN Financial Highlights
Over the last trailing twelve months SCLN reported a non-GAAP Earnings per Share(EPS) of 0.8174. The EPS increased by 9.69% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 25.18% | ||
| ROA | 15.6% | ||
| ROE | 17.34% | ||
| Debt/Equity | 0 |